IMPORTANT : Due to the new rules concerning the Covid pandemics
(effective only on June 9th and afterwards) our face-to-face MS Symposium (initially on June 5th, 2021) is postponed to June 12th 2021.
Location and programme are unchanged.
The ultimate challenge in MS: neuroprotection and remyelination against chronic inflammation
Lectures by Belgian research team leaders
(Dr. P. Maggi, Prof. G. van Loo, Prof. J. Hendriks,
Prof. P. Ponsaerts, Prof. A. des Rieux)
and by two Guest Lecturers,
Prof. Dr. Axel PETZOLD and Prof. Dr. Catherine LUBETZKI
In collaboration with the Belgian Study Group for Multiple Sclerosis
|8:00||Registration – Welcome coffee|
|9:00||Prof. Dr. Christian SINDIC, Chairman Fondation Charcot Stichting|
Prof. Dr. Bénédicte DUBOIS, President Belgian Study Group for Multiple Sclerosis
Welcome and presentation of the symposium.
|9:15||Prof. Dr. Axel PETZOLD (University College London, UK)|
Early MS is already a chronic axonal disease: the case of optic pathways.
|9:45||Dr. Pietro MAGGI (UCLouvain)|
Chronic white matter inflammation and serum neurofilament
levels in multiple sclerosis.
|10:45||Prof. Geert VAN LOO (UGent)|
Microglia in CNS inflammation and MS pathology.
|11:15||Prof. Jerome HENDRIKS (UHasselt)|
Targeting foamy macrophages in MS to promote remyelination.
|11:45||Prof. Dr. Christian SINDIC.|
Charcot Fund 2021: presentation of the laureates.
|14:00||Prof. Peter PONSAERTS (UAntwerpen)|
Neuroprotection by IL13-primed microglia and macrophages: a grey zone between detrimental and protective immunomodulatory therapy for neuro-inflammatory disorders.
|14:30||Prof. Anne des RIEUX (UCLouvain)|
Delivery of therapeutics for the CNS.
|15:00||Prof. Dr. Catherine LUBETZKI (Université Pierre et Marie Curie, Paris)|
Remyelination strategy in multiple sclerosis: from biology to clinical translation.
The sponsors are not involved in the program and content of the symposium